Refractory GERD Symptoms: When to Pursue Further Testing
A 45-year-old woman presents with a 2-year history of heartburn and regurgitation. She has been on omeprazole 40 mg daily for 8 weeks, but her symptoms persist. She reports daily heartburn, especially after meals and when lying down. She also has occasional dysphagia to solids. She has no alarm symptoms such as weight loss, anemia, or GI bleeding. She is a non-smoker, drinks 2 cups of coffee daily, and has a BMI of 32. She has tried lifestyle modifications (elevating head of bed, avoiding late meals) with minimal relief. Her primary care physician ordered an upper endoscopy 1 year ago, which showed Los Angeles grade A esophagitis and a small hiatal hernia. She was prescribed omeprazole 40 mg twice daily, but she admits to taking it only once daily due to cost. She has not tried any other medications. She is concerned about long-term proton pump inhibitor (PPI) use and asks if she can stop them.
1. What is the most appropriate next step in the diagnostic evaluation of this patient's refractory GERD symptoms? Justify your choice.
Read the worked answer
The most appropriate next step is ambulatory esophageal pH monitoring (preferably with impedance) while on PPI therapy to assess for refractory GERD and to correlate symptoms with acid exposure. Before that, ensure the patient is adherent to PPI therapy. She admits to taking omeprazole once daily instead of twice daily. First, optimize PPI adherence and dosing (twice daily before meals). If symptoms persist after 8 weeks of optimized therapy, then proceed with pH-impedance monitoring. Other tests: esophageal manometry to rule out motility disorder (especially with dysphagia), and possibly upper endoscopy to reassess esophagitis and rule out other causes. However, given her prior endoscopy showed grade A esophagitis, and she has dysphagia, manometry may be warranted. But the key is to confirm refractory GERD. The question asks for next step in diagnostic evaluation. The best answer: optimize PPI therapy first (ensure twice-daily dosing and adherence) before further testing. If she is already on twice-daily but nonadherent, address adherence. Since she is on once daily, the next step is to increase to twice daily and reassess in 4-8 weeks. If no improvement, then pH-impedance. So the most appropriate next step is counsel on adherence and increase PPI to twice daily. That is a management step, not a diagnostic test. The question asks for diagnostic evaluation. So if we assume she is optimized, then pH-impedance. But given the history, the first step is to ensure she is on optimal PPI. The model answer should state: The patient is not on optimal PPI therapy. The next step is to confirm adherence and optimize dosing (twice daily) before ordering pH monitoring. If symptoms persist, then pH-impedance. Also, consider manometry if dysphagia persists. So answer: Optimize PPI therapy (twice-daily dosing) and assess adherence; if symptoms persist, proceed with ambulatory pH-impedance monitoring.
2. How would you address the patient's concern about long-term PPI use and her desire to stop them? What are the risks and benefits, and what is your recommendation?
Read the worked answer
Address concerns: PPIs are generally safe for long-term use, but associated with potential risks: C. difficile infection, pneumonia, fractures, hypomagnesemia, B12 deficiency, kidney disease. However, benefits for GERD include symptom control, healing of esophagitis, and prevention of complications (stricture, Barrett's). In this patient with grade A esophagitis and persistent symptoms, continued PPI therapy is appropriate. She should be on twice-daily PPI for refractory symptoms. If she wants to stop, consider on-demand therapy or H2RA if symptoms are mild, but she has erosive esophagitis, so maintenance therapy is needed. Lifestyle modifications (weight loss, head of bed elevation) are important. Surgical options (fundoplication) can be considered if refractory to medical therapy and confirmed GERD. Recommend: Continue PPI, optimize to twice daily, and re-evaluate in 8 weeks. If symptoms persist, consider pH-impedance and manometry. Discuss risks/benefits and reassure that risks are low. Do not stop PPI abruptly; taper if discontinuing. But she should not stop without alternative. Also, address cost: consider generic omeprazole or other PPIs. Weight loss may help. Avoid trigger foods. Follow-up.